Meiji Yasuda Asset Management CO Ltd. Gilead Sciences, Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.32 Billion
- Q1 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 49,050 shares of GILD stock, worth $3.27 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
49,050
Previous 78,550
37.56%
Holding current value
$3.27 Million
Previous $6.36 Million
43.55%
% of portfolio
0.16%
Previous 0.29%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.16 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.64 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.63 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.08 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.84 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $83.5B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...